MedSci Healthcare Holdings Limited (Stock Code: 02415) has scheduled a board meeting for 31 March 2026 in Hong Kong.

The agenda includes: 1. Reviewing and approving the audited financial results of the Group for the financial year ended 31 December 2025. 2. Considering a recommendation for a final dividend. 3. Addressing other routine corporate matters.

The meeting will be chaired by Dr. Zhang Fabao, who serves as Chairman and Executive Director. The current Board comprises four executive directors (Dr. Zhang Fabao, Dr. Li Xinmei, Mr. Wang Shuai, Mr. Cheng Liang), one non-executive director (Mr. Yan Shengfeng), and three independent non-executive directors (Ms. Liu Tao, Mr. Yu Mingyang, Mr. Lau Yiu Kwan Stanley).

The company plans to publish the audited annual results following Board approval. Any final dividend recommendation will be announced after the meeting.